期刊文献+

脑脊液生物学标志物在阿尔茨海默病早期诊断中的作用 被引量:1

Cerebrospinal fluid biomarkers in early diagnosis of Alzheimer's disease
下载PDF
导出
摘要 阿尔茨海默病是一种多因素所致的复杂神经变性疾病,因长期、慢性、进行性脑组织损害而出现一系列认知功能障碍的临床综合症状,也是老年期痴呆最为常见的发病原因。组织病理学以β-淀粉样蛋白(AB)沉积、神经原纤维缠结(NFTs)形成、神经胶质细胞炎症反应和突触功能异常,脑血管淀粉样变和大量神经元缺失,明显脑萎缩为典型特征。
出处 《中国现代神经疾病杂志》 CAS 2014年第4期271-273,共3页 Chinese Journal of Contemporary Neurology and Neurosurgery
关键词 阿尔茨海默病 脑脊髓液 生物学标记 综述 Alzheimer disease Cerebrospinal fluid Biological markers Review
  • 相关文献

参考文献17

  • 1田金洲,时晶,张学凯,倪敬年,张伯礼,王永炎.2011年美国阿尔茨海默病最新诊断标准解读[J].中国医学前沿杂志(电子版),2011,3(4):91-100. 被引量:61
  • 2Blennow K,Zetterberg H.The application of cerebrospinal fluid biomarkers in early diagnosis of Alzheimer disease.Med Clin North Am,2013,97:369-376.
  • 3Engelborghs S.Clinical indications for analysis of Alzheimer’s disease CSF biomarkers.Rev Neurol(Paris),2013,169:709-714.
  • 4Harari O,Cruchaga C,Kauwe JS,Ainscough BJ,Bales K,Picketing EH,Bertelsen S,Fagan AM,Holtzman DM,Morris JC,Goate AM;Alzheimer’s Disease Neuroimaging Initiative.Phosphorylated tau-A β42 ratio as a continuous trait for biomarker discovery for early-stage Alzheimer’s disease in multiplex immunoassay panels of cerebrospinal fluid.Biol Psychiatry,2014.[Epub ahead of print].
  • 5Skillback T,Zetterberg H,Blennow K,Mattsson N.Cerebrospinal fluid biomarkers for Alzheimer disease and subcortical axonal damage in 5,542 clinical samples.Alzheimers Res Ther,2013,5:47.
  • 6Lehmann S,Delaby C,Touchon J,Hirtz C,Gabelle A.Biomarkers of Alzheimer’s disease:the present and the future.Rev Neurol(Paris),2013,169:719-723.
  • 7Zetterberg H,Blennow K.Cerebrospinal fluid biomarkers for AlzheimerJs disease:more to come? J Alzheimers Dis,2013,33:S361-369.
  • 8Mondragon-Rodriguez S,Perry G,Luna-Munoz J,Acevedo-Aquino MC,Williams S.Phosphorylation of tau protein at sites Ser(396-404)is one of the earliest events in Alzheimer’s disease and Down syndrome.Neuropathol Appl Neurobiol,2014,40:121-135.
  • 9Hampel H,Blennow K,Shaw LM,Hoessler YC,Zetterberg H,Trojanowski JQ.Total and phosphorylated tau protein as biological markers of Alzheimer’s disease.Exp Gerontol,2010,45:30-40.
  • 10Jack CR Jr,Knopman DS,Jagust WJ,Petersen RC,Weiner MW,Aisen PS,Shaw LM,Vemuri P,Wiste HJ,Weigand SD,Lesnick TG,Pankratz VS,Donohue MC,Trojanowski JQ.Tracking pathophysiological processes in Alzheimer’s disease:an updated hypothetical model of dynamic biomarkers.Lancet Neurol,2013,12:207-216.

二级参考文献2

  • 1McKhann G;Drachman D;Folstein M.Clinical diagnosis of Alzheimer's disease:report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease[J]Neurology,1984(07):939-944.
  • 2Korczyn AD.Commentary on "Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnost ic guidel ines for Alzheimer's disease"[J]Alzheimer's & Dementia,2011(03):333-334.

共引文献60

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部